Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind cross-over trial evaluating tadalafil 2.5 mg plus sildenafil 25 mg versus tadalafil 5 mg monotherapy (with placebo control) for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)
  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Assiut University | Conditions: Erectile Dysfunction | Phase 3 | Status: NOT_YET_RECRUITING